Tetrahedron Letters
Unexpected cleavage of the Cpy–Cpy bond in the reaction
of 2,20-bipyridine N,N0-diimines with acetylenes
Vyacheslav I. Supranovich a,b, Gennady I. Borodkin a,b, , Aleksey Yu. Vorob’ev a,b, Vyacheslav G. Shubin a
⇑
a Vorozhtsov Novosibirsk Institute of Organic Chemistry, Acad. Lavrentiev Ave. 9, 630090, Russia
b Novosibirsk State University, Pirogov St. 2, 630090, Russia
a r t i c l e i n f o
a b s t r a c t
An unusual cleavage of the Cpy–Cpy bond in the reaction of 2,20-bipyridine N,N0-diimine and its C-methyl
substituted derivatives with acetylenes is described. The effect of the solvent on the yield of 7,70-bipyraz-
olo[1,5-a]pyridine-2,20,3,30-tetracarboxylates and the products of cleavage of the Cpy–Cpy bond has been
studied. The mechanism of the cleavage reaction is discussed on the basis of DFT calculations.
Ó 2014 Elsevier Ltd. All rights reserved.
Article history:
Received 30 May 2014
Revised 11 July 2014
Accepted 6 August 2014
Available online 13 August 2014
Keywords:
1,3-Dipolar cycloaddition
N-Amine salts
Pyrazolo[1,5-a]pyridines
DFT calculations
C
sp2–Csp2 bond cleavage
Pyrazolo[1,5-a]pyridine derivatives are an important class of
that this reaction was completely analogous with the behavior of
pyridine N-imines, though the yield of the adduct was very low
(8%). However, we have found that the 1,3-dipolar cycloaddition
is accompanied by cleavage of the Cpy–Cpy bond.
When salts 1a–c were treated with K2CO3 and reacted with
DMAD, products of both normal 1,3-dipolar cycloaddition (2a–c)
and unexpected C–C0-bipyridyl bond cleavage (3a–d) were formed
(Scheme 1).18
nitrogen-containing heterocycles with a wide range of biological
activities such as diuretic,1 antiplatelet,2 antiviral,3 and anti-ische-
mic.4 Substituted pyrazolo[1,5-a]pyridines act as ligands for a
number of receptors, for example, D3, D4, 5HT3, melatonin, and
adenosine A1.1,5–7 Pyrazolopyridines are found among numerous
systems that affect the central nervous system. The dopamine D3
receptor subtype is associated with several neuropathologies such
as schizophrenia, unipolar major depression, attention-deficit dis-
order, and Parkinson’s disease.7a
Insertion of the electron-donor methyl groups at the 4,40 and
5,50 positions of the pyridine rings had no significant effect on
the ratio of the expected cycloaddition products 2 and fragmenta-
tion products 3 (Table 1, in the Supplementary material). The ratio
of the products 2 and 3 depends on the solvent used. When toluene
was used as the solvent, bipyridyls 4a,b were also obtained. It was
also observed that when an argon atmosphere was used instead of
air, no appreciable effect on the yield of 2a and ratio of 2a/3a
occurred (Table 2, entries 3 and 4 in the Supplementary material).
Acetylenes other than DMAD behaved similarly under the same
reaction conditions (Scheme 2) (cf. Ref. 24).
Due to the importance of pyrazolo[1,5-a]pyridine derivatives as
substructures in drug design, many efforts have been devoted to
the development of efficient protocols for their preparation.3b,5–17
The most commonly used method for the synthesis of pyrazol-
o[1,5-a]pyridines is via 1,3-cycloaddition of pyridine N-imines
with alkyne or alkene derivatives.3b,5–17 Over the past four decades,
the 1,3-dipolar properties of N-imines have been investigated
intensively.7d,9,10,12–17
However, information on the behavior of N,N0-diimines in this
reaction is quite limited. Tamura et al. reported that N,N0-dia-
A theoretical study based on DFT analysis26 at the RI-B3LYP/
6-31G(d,p) level of theory with the SMD solvation model27 was
performed to examine the possible mechanism of the reaction,
and to find a reaction path that accounts for the abnormal behavior
of the N,N0-diimino-2,20-bipyridyl salts (Scheme 3 and Fig. 1 in the
Supplementary material).28
mino-4,40-dimethyl-2,20-bipyridinium
dimesitylenesulfonate
underwent reaction with dimethyl acetylenedicarboxylate
(DMAD) under basic conditions to give a 1:2 adduct.17 It was found
The complete process for the formation of the abnormal product
3a is highly exothermic. It is very probable that the rate-limiting
⇑
Corresponding author. Tel.: +7 (383) 330 7651; fax: +7 (383) 330 9752.
0040-4039/Ó 2014 Elsevier Ltd. All rights reserved.